Acrux heads to the Finnish

By Dylan Bushell-Embling
Thursday, 14 August, 2008

Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.

Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.

Acrux retains the rights to supply the products to licensees in all territories.

Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.

Related News

Ultra-processed foods linked to poor health, premature death

Evidence suggests a dose-response relationship between ultra-processed food consumption and...

Shorter radiotherapy course proves safe for prostate cancer

A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...

5-in-1 meningococcal vaccine proves effective

A life-saving meningococcal vaccine covering all five common strains of the deadly disease could...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd